Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Lease Term and Discount Rate

Financing liability information was as follows (dollars in thousands):


	December 31, 2023			December 31, 2022
Weighted average remaining lease term (in years)		17.8			18.8
Weighted average discount rate		9.0	%		9.0	%

Lease information was as follows (dollars in thousands):


	December 31, 2023			December 31, 2022
Operating lease right-of-use assets(1)	$	4,685		$	6,714

Operating lease liability-current(2)	$	1,423		$	1,304
Operating lease liability-long-term		3,925			5,343
Total	$	5,348		$	6,647

Weighted average remaining lease term (in years)		3.7			4.6
Weighted average discount rate		7.3	%		7.3	%

__________________________

(1)

Operating right-of-use assets related to vehicles, offices and the manufacturing facility are included in other assets in the consolidated balance sheets.

(2)

Operating lease liability – current are included in accrued expenses and other current liabilities in the consolidated balance sheets.

Summary of Lease Information


	Year Ended December 31,
	2023		2022		2021
Interest expense on financing liability	$	9,825	$	9,758	$	1,373


	Year Ended December 31,
	2023		2022		2021
Operating lease costs	$	1,675	$	1,525	$	863
Variable lease costs		104		274		515
Cash paid		1,068		1,823		1,867

Summary of Financing Liability Payments

The Company's remaining financing liability payments were as follows (in thousands):


	December 31, 2023
2024	$	10,018
2025		10,269
2026		10,533
2027		10,849
2028		11,174
Thereafter		177,278
Total		230,121
Interest payments		(123,318	)
Debt issuance costs		(2,675	)
Total financing liability	$	104,128

Remaining Purchase Commitments and Estimated Capacity Fee Liability Requirements

The Company's remaining purchase commitments and estimated capacity fee liability as of December 31, 2023, as well as pre-amendment purchase commitments as of September 30, 2023, were as follows (€ in millions):


	December 31, 2023				September 30, 2023
	Remaining Purchase Commitments		Estimated Capacity Fees		Remaining Purchase Commitments
2023		—		—		2.4
2024		2.9		—		14.6
2025		—		1.5		15.5
2026(1)		4.2		2.0		19.4
2027		6.0		1.0		9.2
2028		6.0		1.0		—
2029		6.0		1.0		—
2030		6.0		1.0		—
2031		8.0		0.5		—
2032		8.0		0.5		—
2033		8.0		0.5		—
2034		4.4		0.5		—
Total		59.5		9.5		61.1

__________________________

(1)

If there is a delay in the availability of insulin with FDA approved inclusion bodies and supply does not begin in 2026 as currently expected, the Company will incur a capacity fee of €750,000 per quarter that the product is not available for purchase.

Schedule of Future Minimum Office And Vehicle Lease Payments

The Company's future minimum office and vehicle lease payments were as follows (in thousands):


	December 31, 2023
2024	$	1,496
2025		1,861
2026		1,140
2027		1,072
2028		643
Total		6,212
Interest expense		(864	)
Total operating lease liability	$	5,348